4th Quarter - Report

TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act.

LobbyistCovered position, as disclosed
ANDREW MCKECHNIE —
TIMOTHY ROBINSON —
JOHN KIRKLAND TWOMEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5378 (118th)

Health Issues HCR

Issues related to insurance coverage, prescription drugs, pharmacy policy, and employer sponsored insurance; H.R.5378 - Lower Cost, More Transparency Act.

LobbyistCovered position, as disclosed
ANDREW MCKECHNIE —
TIMOTHY ROBINSON —
JOHN KIRKLAND TWOMEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5378 (118th)

Defense DEF

Pharmacy issues related to TRICARE; H.R.2670/S.2226 - Fiscal Year 2024 National Defense Authorization Act.

LobbyistCovered position, as disclosed
ANDREW MCKECHNIE —
TIMOTHY ROBINSON —
JOHN KIRKLAND TWOMEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2670 (118th), S. 2226 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.